Supha Pharmachem Limited (BOM:539561)
India
· Delayed Price · Currency is INR | Market Cap | 165.31M |
| Revenue (ttm) | 5.27B |
| Net Income (ttm) | 122.54M |
| Shares Out | 403.20M |
| EPS (ttm) | 0.19 |
| PE Ratio | 2.19 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 10,523,230 |
| Average Volume | 12,737,905 |
| Open | 0.410 |
| Previous Close | 0.430 |
| Day's Range | 0.410 - 0.430 |
| 52-Week Range | 0.410 - 2.640 |
| Beta | 0.89 |
| RSI | 10.64 |
| Earnings Date | Feb 14, 2026 |
About Supha Pharmachem
Supha Pharmachem Limited, a pharmaceutical company, trades and sells active pharmaceutical ingredients (API) and intermediates in India and internationally. The company offers API intermediates and other products for the use in iso propyl alcohol, cyclohexane di iso propyl amine, ethyl acetate, hydrazine hydrate, iso propyl alcohol, methylene di chloride, potassium carbonate powder, sodium bi-carbonate, potassium hydroxide flakes, sodium chloride and carbonate, amino isophthalic acid, tellurium(iv) oxide, grignard reagent, iodine, selenium meta... [Read more]
Financial Performance
In fiscal year 2025, Supha Pharmachem's revenue was 4.05 billion, a decrease of -89.97% compared to the previous year's 40.42 billion. Earnings were 21.29 million, a decrease of -93.49%.
Financial StatementsNews
Remedium Lifecare strengthens leadership for next-phase growth
Mumbai, November 10, 2025: Remedium Lifecare Ltd., a fast-emerging player in the pharmaceutical supply chain and specialty chemicals sector, has...